Liangshun You

1.6k total citations
45 papers, 1.0k citations indexed

About

Liangshun You is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Liangshun You has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Hematology and 13 papers in Oncology. Recurrent topics in Liangshun You's work include Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Virus-based gene therapy research (5 papers). Liangshun You is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Lymphoma Diagnosis and Treatment (6 papers) and Virus-based gene therapy research (5 papers). Liangshun You collaborates with scholars based in China. Liangshun You's co-authors include Wenbin Qian, Qingmei Han, Shenhe Jin, Qingqing Lin, Haitao Meng, Jie Jin, Xianbo Huang, Li Zhu, Liping Mao and Zhu Li and has published in prestigious journals such as Blood, Oncogene and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Liangshun You

42 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangshun You China 19 434 247 216 174 154 45 1.0k
István Vályi‐Nagy Hungary 20 499 1.1× 241 1.0× 359 1.7× 150 0.9× 201 1.3× 90 1.4k
Feifei Liu China 17 371 0.9× 272 1.1× 147 0.7× 127 0.7× 257 1.7× 54 1.1k
Rashi Singhal United States 11 474 1.1× 127 0.5× 120 0.6× 80 0.5× 102 0.7× 26 1.0k
Ling Yuan Kong Canada 12 317 0.7× 264 1.1× 262 1.2× 191 1.1× 243 1.6× 29 1.1k
Chaofan Li China 18 293 0.7× 141 0.6× 152 0.7× 191 1.1× 417 2.7× 73 1.1k
Francesco Marchesi Italy 19 249 0.6× 274 1.1× 346 1.6× 214 1.2× 105 0.7× 79 1.1k
Jennifer M. Kwan United States 16 397 0.9× 270 1.1× 145 0.7× 96 0.6× 159 1.0× 51 1.2k
Farhan Cyprian Qatar 18 353 0.8× 266 1.1× 279 1.3× 171 1.0× 340 2.2× 42 1.3k
Bowen Zhang China 16 268 0.6× 379 1.5× 117 0.5× 85 0.5× 249 1.6× 57 1.2k

Countries citing papers authored by Liangshun You

Since Specialization
Citations

This map shows the geographic impact of Liangshun You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangshun You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangshun You more than expected).

Fields of papers citing papers by Liangshun You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangshun You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangshun You. The network helps show where Liangshun You may publish in the future.

Co-authorship network of co-authors of Liangshun You

This figure shows the co-authorship network connecting the top 25 collaborators of Liangshun You. A scholar is included among the top collaborators of Liangshun You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangshun You. Liangshun You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Xuejiao, Yi Liu, Jianping Ge, et al.. (2025). IFN-γ promotes the progression of iMCD by activating inflammatory monocytes. Blood. 146(1). 76–88.
2.
Yang, Min, Yu Chen, Li Zhu, et al.. (2024). Harnessing Nanotechnology: Emerging Strategies for Multiple Myeloma Therapy. Biomolecules. 14(1). 83–83. 14 indexed citations
3.
Yin, Xuejiao, Yi Liu, Liya Ma, et al.. (2024). scRNA‐seq reveals the landscape of immune repertoire of PBMNCs in iMCD. Oncogene. 43(37). 2795–2805. 1 indexed citations
4.
Yin, Xuejiao, et al.. (2023). Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting. Therapeutic Advances in Chronic Disease. 14. 384261827–384261827. 1 indexed citations
5.
Yin, Xuejiao, Xuelian Hu, Hongyan Tong, & Liangshun You. (2023). Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype. Therapeutic Advances in Chronic Disease. 14. 384222467–384222467. 3 indexed citations
6.
7.
Zhang, Xinlu, et al.. (2022). The mechanisms and cross-protection of trained innate immunity. Virology Journal. 19(1). 210–210. 13 indexed citations
8.
Yang, Chunmei, Liangshun You, & Haitao Meng. (2021). Massive limb lymphedema as the initial presentation of multiple myeloma: a case report. Translational Cancer Research. 10(3). 1599–1602. 2 indexed citations
9.
10.
Lin, Qingqing, Zhu Li, Zuowei Ni, Haitao Meng, & Liangshun You. (2020). Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection. Journal of Microbiology Immunology and Infection. 53(5). 821–822. 71 indexed citations
11.
You, Liangshun, Fan Yang, Qing Yang, et al.. (2020). <p>Echinocandins versus Amphotericin B Against <em>Candida tropicalis</em> Fungemia in Adult Hematological Patients with Neutropenia: A Multicenter Retrospective Cohort Study</p>. Infection and Drug Resistance. Volume 13. 2229–2235. 7 indexed citations
12.
Han, Qingmei, Qingqing Lin, Shenhe Jin, & Liangshun You. (2020). Coronavirus 2019-nCoV: A brief perspective from the front line. Journal of Infection. 80(4). 373–377. 220 indexed citations
13.
Zhang, Yi, Hanjin Yang, Xinping Zhou, et al.. (2020). Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study. Journal of Cancer Research and Clinical Oncology. 146(2). 357–365. 7 indexed citations
14.
You, Liangshun, Qingmei Han, Li Zhu, et al.. (2020). Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells. Frontiers in Immunology. 11. 1787–1787. 61 indexed citations
15.
Chen, Zhenzhen, Liangshun You, Lei Wang, et al.. (2018). Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo. Journal of Experimental & Clinical Cancer Research. 37(1). 190–190. 68 indexed citations
16.
You, Liangshun, Liping Mao, Juying Wei, et al.. (2017). The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses. Journal of Hematology & Oncology. 10(1). 165–165. 35 indexed citations
17.
He, Wei, Xiujin Ye, Xianbo Huang, et al.. (2016). Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells. International Journal of Oncology. 48(4). 1710–1720. 34 indexed citations
18.
Zhou, Yuhong, et al.. (2015). Matrine and CYC116 synergistically inhibit growth and induce apoptosis in multiple myeloma cells. Chinese Journal of Integrative Medicine. 21(8). 635–639. 8 indexed citations
19.
20.
Meng, Haitao, Li Zhu, Wanmao Ni, et al.. (2011). Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1*. Acta Pharmacologica Sinica. 32(4). 503–511. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by István Vályi‐Nagy Breakdown of academic impact, for papers by Feifei Liu Breakdown of academic impact, for papers by Rashi Singhal Breakdown of academic impact, for papers by Ling Yuan Kong Breakdown of academic impact, for papers by Chaofan Li Breakdown of academic impact, for papers by Francesco Marchesi Breakdown of academic impact, for papers by Jennifer M. Kwan Breakdown of academic impact, for papers by Farhan Cyprian Breakdown of academic impact, for papers by Bowen Zhang
Rankless by CCL
2026